sivelestat has been researched along with Shock, Septic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hagiwara, S; Iwasaka, H; Noguchi, T; Togo, K | 1 |
| Murakami, K; Okabe, H; Okajima, K; Takatsuki, K; Uchiba, M | 1 |
2 other study(ies) available for sivelestat and Shock, Septic
| Article | Year |
|---|---|
A neutrophil elastase inhibitor, sivelestat, reduces lung injury following endotoxin-induced shock in rats by inhibiting HMGB1.
Topics: Animals; Glycine; HMGB1 Protein; Interleukin-6; Leukocyte Elastase; Lipopolysaccharides; Lung; Lung Injury; Male; NF-kappa B; Nitrates; Nitrites; Rats; Rats, Wistar; Serine Proteinase Inhibitors; Shock, Septic; Sulfonamides; Tumor Necrosis Factor-alpha | 2008 |
Endotoxin-induced pulmonary vascular injury is mainly mediated by activated neutrophils in rats.
Topics: Amino Acid Chloromethyl Ketones; Amino Acid Sequence; Animals; Anticoagulants; Antithrombin III; Capillary Permeability; Dansyl Compounds; Endotoxins; Factor Xa; Fibrin Fibrinogen Degradation Products; Glycine; Heparin; Injections, Intravenous; Leukocyte Elastase; Leukopenia; Lipopolysaccharides; Lung; Male; Methotrexate; Molecular Sequence Data; Neutrophils; Pancreatic Elastase; Pulmonary Circulation; Pulmonary Edema; Rats; Rats, Wistar; Shock, Septic; Specific Pathogen-Free Organisms; Sulfonamides | 1995 |